GLP-1 is similar to but unlike GIP, actions of GLP-1 are better preserved in type 2 diabetes mellitus (T2DM) patients, which makes it a highly desirable target for drug discovery for T2DM (Sharma and Bhatia, 2020)
Dulaglutide (Trulicity) : Once-weekly injection approved for type 2 diabetes, with demonstrated cardiovascular benefits
Ready to Boost Your Health and Energy
DSIP may to some extent regulate the oxidative stress response induced by electromagnetic fields
This therapy is ideal for individuals with osteoarthritis or musculoskeletal injuries who cannot tolerate corticosteroid injections, have contraindications to steroids, or have not experienced relief from prior steroid or viscosupplementation treatments
Yet Cannabis is Schedule 1 while alcohol kills 95,000 Americans every year